Using a combination of genome‐wide CRISPR, RNA, and chromatin immunoprecipitation (ChIP)‐ sequencing analyses, Lytle, et al.[60] identified a new role for nuclear hormone receptor retinoic‐acid‐receptor‐related orphan receptor gamma (RORγ) in promoting pancreatic cancer progression. The gene discussed is RORC; the disease is familial pancreatic carcinoma.